NZ745686A - Lipid nanoparticle compositions and methods for mrna delivery - Google Patents

Lipid nanoparticle compositions and methods for mrna delivery

Info

Publication number
NZ745686A
NZ745686A NZ745686A NZ74568612A NZ745686A NZ 745686 A NZ745686 A NZ 745686A NZ 745686 A NZ745686 A NZ 745686A NZ 74568612 A NZ74568612 A NZ 74568612A NZ 745686 A NZ745686 A NZ 745686A
Authority
NZ
New Zealand
Prior art keywords
lipid nanoparticle
methods
nanoparticle compositions
mrna delivery
composition
Prior art date
Application number
NZ745686A
Inventor
Braydon Guild
Frank Derosa
Michael Heartlein
Original Assignee
Translate Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Translate Bio Inc filed Critical Translate Bio Inc
Priority claimed from NZ719345A external-priority patent/NZ719345A/en
Publication of NZ745686A publication Critical patent/NZ745686A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Disclosed is a composition comprising (a) at least one mRNA molecule at least a portion of which encodes a functional secreted polypeptide; and (b) a transfer vehicle comprising a lipid nanoparticle. Also disclosed is the use of the said composition for the treatment of a subject having a deficiency in a functional polypeptide.
NZ745686A 2011-06-08 2012-06-08 Lipid nanoparticle compositions and methods for mrna delivery NZ745686A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161494881P 2011-06-08 2011-06-08
NZ719345A NZ719345A (en) 2011-06-08 2012-06-08 Lipid nanoparticle compositions and methods for mrna delivery

Publications (1)

Publication Number Publication Date
NZ745686A true NZ745686A (en) 2022-09-30

Family

ID=83933066

Family Applications (2)

Application Number Title Priority Date Filing Date
NZ734700A NZ734700A (en) 2011-06-08 2012-06-08 Lipid nanoparticle compositions and methods for mrna delivery
NZ745686A NZ745686A (en) 2011-06-08 2012-06-08 Lipid nanoparticle compositions and methods for mrna delivery

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NZ734700A NZ734700A (en) 2011-06-08 2012-06-08 Lipid nanoparticle compositions and methods for mrna delivery

Country Status (1)

Country Link
NZ (2) NZ734700A (en)

Also Published As

Publication number Publication date
NZ734700A (en) 2023-01-27

Similar Documents

Publication Publication Date Title
NZ719345A (en) Lipid nanoparticle compositions and methods for mrna delivery
IL283459A (en) Novel lipids and compositions for the delivery of therapeutics
PH12016502066A1 (en) Methods of treating bladder cancer
WO2014145159A3 (en) Charge-engineered antibodies or compositions of penetration-enhanced targeting proteins and methods of use
NZ718817A (en) Lipid formulations for delivery of messenger rna
WO2013084000A3 (en) Exosomes for delivery of biotherapeutics
WO2009149418A3 (en) Compositions for the in vivo delivery of rnai agents
SG10201804552WA (en) Nanoparticle compositions, formulations thereof, and uses therefor
MX346224B (en) Compostions and methods for treating chronic inflammation and inflammatory diseases.
IL234550A (en) Aminoacid lipid carrier systems and compositions for use in targeted delivery
TR201816986T4 (en) Lipids for therapeutic agent delivery formulations.
HK1220631A1 (en) Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same
TN2013000310A1 (en) Effervescent composition in solid form for use in vaginal applications for the treatment of vaginal infections
MX2019000225A (en) Compositions and methods for treatment of autoimmune and other disease.
MX355877B (en) Therapeutic peptides.
IN2014MN01886A (en)
GR1008018B (en) Lipid assemblies comprising anionic lysolipids and use thereof
MX2013008175A (en) Pharmaceutical compositions for topical delivery of photosensitizers and uses thereof.
WO2012040331A3 (en) Multistage nanoparticles
SG191060A1 (en) Robo1-fc fusion protein for use in the treatment of hepatocarcinoma
MX360411B (en) Use of thiosulphate in order to potentiate the anti-pathogen effect of lactobacillus.
ZA201203028B (en) Compositions, use and method for the use of surface active proteins in topical drug delivery across keratin
WO2014039074A3 (en) Therapeutic compositions and related methods
UA117567C2 (en) Galactagogue compositions based on phosphatidylserine
WO2014104989A8 (en) Pharmaceutical compositions comprising aripiprazole

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 9 YEARS UNTIL 08 JUN 2025 BY PIZZEYS PATENT AND TRADE MARK ATTORNEYS PTY LTD

Effective date: 20230217